FDA Inspection 1205083 — Renata PLC (General Plant 2)
The FDA completed an inspection of Renata PLC (General Plant 2) on Jan 30, 2020 in Gazipur. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 30, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gazipur (Bangladesh)
Additional Details
Mutual Recognition Agreement (MRA)